RxDoctor Payments Data

Christina Randall, PA

Medical · Greenville, SCNPI 1518112689

Payments from drug & device makers

$2,004in general payments, 2019–2025

Across 45 payments — averaging $44.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$658
  • Spinal Simplicity, LLC$373
  • Medtronic$250
  • Averitas Pharma Inc.$202
  • GRT US Holding, Inc.$197
  • Vertos Medical, Inc.$127
  • plus $198 from 8 others

What the payments were for

  • Food & beverage$2,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,004 in reported general payments places this provider in the 65th percentile of 384 medical providers in South Carolina.

See all medical providers in South Carolina

Medicare billing

Part B allowed, 2024
$41,461
Medicare patients
218
Services billed
2,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
QutenzaCapsaicin/Skin Cleanser12$40,279
Aimovig AutoinjectorErenumab-Aooe12$8,575
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen318$6,372
Buprenorphine33$6,084
Gabapentin321$4,308
Pregabalin195$3,860
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen139$3,513
Lidocaine16$1,898
Tizanidine Hcl144$1,448
Oxycodone Hcl86$1,122
Tramadol Hcl211$1,073
Baclofen68$1,022
Methocarbamol52$814
Celecoxib46$738
Duloxetine Hcl45$715

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GRT US Holding, Inc.Qutenza$197$40,27912 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$17$6,25249 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 384 medical providers in South Carolina.

Other medical in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →